Drew Moghanaki MD
Thoracic Cancer
Professor | Chief of Thoracic Oncology | UCLA Department of Radiation Oncology
Join to view full profile
200 Medical Plaza , Suite 165-47Los Angeles, CA 90095
Phone+1 310-794-2177
Fax+1 310-794-2177
Dr. Moghanaki is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Drew Moghanaki is a radiation oncologist at UCLA. He received his medical degree from Vanderbilt University School of Medicine and has been in practice 15 years. He specializes in thoracic cancer and is experienced in lung cancer and stereotactic body radiation therapy. He has more than 80 publications and over 500 citings.
Education & Training
University of Pennsylvania Health SystemResidency, Radiation Oncology, 2003 - 2007
Vanderbilt University Medical CenterInternship, Surgery, 2002 - 2003
Vanderbilt University School of MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2021 - 2027
GA State Medical License 2018 - 2022
VA State Medical License 2008 - 2020
TN State Medical License 2011 - 2012
PA State Medical License 2003 - 2008
DE State Medical License 2004 - 2005
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Most Compassionate Doctor American Registry
Clinical Trials
- Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal Injury
- Hydroxychloroquine in Treating Patients With Solid Tumors Undergoing Radiation Therapy for Bone Metastases
- Randomized RT +/- Lapatinib for Advanced Solid Tumor Cancer Patients Receiving Radiation Therapy for Metastatic Disease
Publications & Presentations
PubMed
- Veteran Satisfaction With Lung Cancer Screening Care: A Cross-Sectional Evaluation.Jennifer A Lewis, Amber J Hackstadt, Kathryn D Snyder, Lauren R Samuels, Daniel Park
Medical Care. 2026-09-01 - Inconsistent definitions of local control for stereotactic body radiation therapy for early-stage lung cancer - A systematic review.Niki Nourmohammadi, Camellia Kashani, Talia Oughourlian, John Nikitas, Jie Deng
Radiotherapy and Oncology. 2026-09-01 - Efficacy and safety of adrenalectomy and stereotactic ablative radiotherapy (SABR) for adrenal metastases: A systematic review and meta-analysis.Nicolas Giraud, Peter S N van Rossum, Sasha Ebrahimi, Miguel A Palacios, Drew Moghanaki
Radiotherapy and Oncology. 2026-08-01
Journal Articles
- Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer with Adverse Pathological FeaturesRahul D. Tendulkar, Kevin L. Stephans, Stanley L. Liauw, Robert B. Den, Shre Agrawal, Jason A. Efstathiou, Thomas M. Pisansky, Jason W. Hearn, Jef M. Michalski, Drew M..., JAMA
Authored Content
- Management of Metastatic Spinal Cord Compression Among Veterans Health Administration Radiation OncologistsMarch 2018
Press Mentions
Half of Patients with Advanced Lung Cancer Don’t Get Treatment, Study FindsMay 7th, 2026- Abysmal Screening Rates Hamper Fight Against America’s Deadliest CancerNovember 24th, 2025
- The Key to Fighting Lung Cancer Is More Screenings, New Study ShowsNovember 19th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
